New Delhi: Indian pharma industry is the only industry which is known as recession free industry. World is facing serious economic crunch but Indian pharma industry marked record growth. The Indian pharmaceutical market has for the first time crossed the Rs 100000 crore mark in November when calculated on the basis of Moving Annual Total (MAT), said IMS Health, a global pharmaceutical market research firm.In its monthly review of the local market, IMS Health said in its note titled Market Reflections that Indian companies took over three-fourth of the market share during the month.
India is one of the polluted country in the world and Delhi ranks no.1 with 470 in pollution index and on 25th December pollution level was more than the Diwali. Healthy pollution index is below 50. In pharma sector growth pollution plays a vital role. On an average over the last three years, Indian pharmaceutical market has grown by 12%. Almost 38% of the market was dominated by drugs that treat infections, heart ailments and patients with gastro-intestinal issues. IMS report said in November, Indian market was at Rs 100115 crore, of which the retail sector was valued at Rs 84279 crore.
Sun Pharma remained at the top of the list of drug companies with a market share of 8%, followed by Abbott with a share of 6.1%. Cipla trailed at 5.4% but grew higher than its top peers showing growth of 16% during the month. Mankind Pharma has jumped past its traditional rivals to secure the fourth position with a market share of 3.7%, standing above Alkem, GlaxoSmithKline and ZydusCadila. Mixtard, a popular insulin marketed by Abbott, continued to hold the position of the largest brand for the month followed by Pfizer cough syrup Corex and Glycomet-gp, a
diabetes brand of USV.India’s pharma industry may touch $55 billion by 2020: Assocham and TechSci report, 28 December 2015.Salute to Shree NarendraModiJi and BJP as a whole team for planning for pharma as an industry by 2016 and launching of make in Indiaplan. First time in Indian history we have got fearless and visionary PM and we are confident that pharma industry will reach to the height of pinnacle in his regime.
Indian pharma industry has moving towards a global leadership path and our medicine is globally accepted. Every 3rd medicine in the world is Indian medicine. India is the pharmacy of the world.
Pharma majors should share more for clean India campaign because they are directly beneficiaries of pollution induced infections and other disorders. In corporate social responsibility, Wipro and other IT firm doing extraordinary contribution.